L
Edit properties
Sector
Biotechnology
Status
active
Stage
Series D+
HQ City
—
Subsector
Neuro-metabolic therapeutics
Founded
—
AKA
—
Website
—
Notes
—
+ Add financial data — ARR, revenue, headcount, EBITDA
Latest news
From Google NewsNo news yet. Click Refresh to pull from Google News.
Funding Rounds
| Round | Amount | Post-Money Val. | Date | Lead | All Investors | |
|---|---|---|---|---|---|---|
| Series D+ | $30M | — | 2026-08-18 | — | Eli Lilly, OrbiMed, Newpath Partners, Euclidean Capital, SV Health Investors, Chugai Venture Fund, Alexandria Venture Investments, PhiFund | ↗ comps |